URINARY MICRORNA IN BLADDER CANCER - A POTENTIAL DIAGNOSTIC TOOL

URINARY MICRORNA IN BLADDER CANCER - A POTENTIAL DIAGNOSTIC TOOL

Detalhes bibliográficos
Main Authors:	Miah, S, Dudziec, E, Rosario, D, Hamdy, F, Catto, J
Formato:	Journal article
Publicado em:	2011

Registos relacionados

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer
Por: Miah, S, et al.
Publicado em: (2012)

An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer.
Por: Miah, S, et al.
Publicado em: (2012)

Hypermethylation of CpG islands and shores around specific microRNAs and mirtrons is associated with the phenotype and presence of bladder cancer.
Por: Dudziec, E, et al.
Publicado em: (2011)

Distinct microRNA alterations characterize high- and low-grade bladder cancer.
Por: Catto, J, et al.
Publicado em: (2009)

Distinct microRNA alterations characterize high- and low-grade bladder cancer
Por: Catto, J, et al.
Publicado em: (2009)

Artificial intelligence technique for gene expression profiling of urinary bladder cancer
Por: Abbod, M, et al.
Publicado em: (2006)

Artificial intelligence technique for gene expression profiling of urinary bladder cancer
Por: Abbod, M, et al.
Publicado em: (2006)

MicroRNA in prostate, bladder, and kidney cancer: A systematic review
Por: Catto, J, et al.
Publicado em: (2011)

MicroRNA in prostate, bladder, and kidney cancer: a systematic review.
Por: Catto, J, et al.
Publicado em: (2011)

Aberrant promoter methylation in pre-malignant and invasive tumours of the urinary bladder
Por: Yates, D, et al.
Publicado em: (2005)

Artificial intelligence for the prediction bladder cancer
Por: Abbod, M, et al.
Publicado em: (2004)

Targeting chemotherapy to advanced bladder cancer patients most likely to benefit.
Por: Catto, J, et al.
Publicado em: (2010)

Artificial urinary bladder model
Por: Read, B, et al.
Publicado em: (2024)

Recent Developments in the Search for Urinary Biomarkers in Bladder Cancer
Por: Leiblich, A
Publicado em: (2017)

Comparative study of intelligent models for the prediction of bladder cancer progression.
Por: Abbod, M, et al.
Publicado em: (2006)

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
Por: van Oers, J, et al.
Publicado em: (2009)

Neuro-fuzzy modeling: an accurate and interpretable method for predicting bladder cancer progression.
Por: Catto, J, et al.
Publicado em: (2006)

Sequence variant on 8q24 confers susceptibility to urinary bladder cancer.
Por: Kiemeney, L, et al.
Publicado em: (2008)

Sequence variant on 8q24 confers susceptibility to urinary bladder cancer
Por: Kiemeney, L, et al.
Publicado em: (2008)

Promoter hypermethylation identifies progression risk in bladder cancer.
Por: Yates, DR, et al.
Publicado em: (2007)

Artificial intelligence and bladder cancer arrays.
Por: Wild, P, et al.
Publicado em: (2007)

Scrotal displacement of the urinary bladder in a pig
Por: Tan, H. S., et al.
Publicado em: (1982)

Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
Por: Catto, J, et al.
Publicado em: (2009)

Genetic instability and transitional cell carcinoma of the bladder.
Por: Catto, J, et al.
Publicado em: (2004)

Electrical impedance spectroscopy (EIS) in the urinary bladder: the effect of inflammation and edema on identification of malignancy.
Por: Smallwood, R, et al.
Publicado em: (2002)

Immature teratoma of the urinary bladder: a case report
Por: Perpustakaan UGM, i-lib
Publicado em: (2003)

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer.
Por: Kiemeney, L, et al.
Publicado em: (2010)

Development of a prognostic marker panel in bladder cancer using aberrant promoter methylation
Por: Catto, J, et al.
Publicado em: (2007)

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.
Por: Yates, DR, et al.
Publicado em: (2006)

Hypoxia regulated miRNAs in bladder cancer
Por: Blick, C, et al.
Publicado em: (2012)

Reply from Authors re: David J. DeGraff. Novel Use of a Combined Artificial Intelligence Approach to Identify Patients with Noninvasive Urothelial Cell Carcinoma of the Urinary Bladder Who Are at Greatest Risk for Progression to Muscle-Invasive Disease: A Step Forward. Eur Urol 2010; 57: 407-8
Por: Catto, J, et al.
Publicado em: (2010)

Changes in circulating microRNA levels associated with prostate cancer.
Por: Bryant, R, et al.
Publicado em: (2012)

Circulating microRNAs are associated with the development and progression of prostate cancer
Por: Bryant, R, et al.
Publicado em: (2012)

Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer.
Por: Wu, X, et al.
Publicado em: (2009)

MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential.
Por: Ballabio, E, et al.
Publicado em: (2010)

The application of artificial intelligence to microarray data: identification of a novel gene signature to identify bladder cancer progression.
Por: Catto, J, et al.
Publicado em: (2010)

Induction of insulin-like growth factor binding protein-3 by hypoxia and increased urinary excretion in bladder cancer.
Por: Ord, J, et al.
Publicado em: (2003)

Studies on the effects of N-ethylmaleimide (NEM) in the urinary bladder of Bufo marinus
Por: Marples, D
Publicado em: (1990)

Comparing gene promoter methylation frequencies in urine from patients with bladder cancer with urine from non-cancerous young and elderly control patients
Por: Yates, DR, et al.
Publicado em: (2005)

Artificial intelligence in predicting bladder cancer outcome: a comparison of neuro-fuzzy modeling and artificial neural networks.
Por: Catto, J, et al.
Publicado em: (2003)